SCHEMBL6509592

SCHEMBL6509592

[C]c1ccc(-c2cccc(C=O)c2O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 12/20 0.50
TLR2 O60603 1/20 0.43
TLR1 Q15399 1/20 0.43
TLR6 Q9Y2C9 1/20 0.43
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
HNF4A P41235 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
XDH P47989 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31364059 0.83 ERN1 (0.55) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL1043113 0.83 ERN1 (0.55) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL3966538 0.82 ERN1 (0.50) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL5735298 0.82 ERN1 (0.52) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL2560945 0.82 ERN1 (0.50) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL5735469 0.82 ERN1 (0.56) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL31152506 0.80 ERN1 (0.67) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL16439936 0.80 ERN1 (0.67) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL2561443 0.79 ERN1 (0.53) ERN1TLR2TLR1TLR6TRIM24
SCHEMBL1423844 0.79 ERN1 (0.50) ERN1TLR2TLR1TLR6TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050148646-A1 Dicationic triaryl analogs as anti-protozoan agents BOYKIN DAVID W (US) 2005-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148646-A1 Dicationic triaryl analogs as anti-protozoan agents DDT, DDC, DARS1 ERN1 3847/4885TLR2 844/4885TLR1 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.